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Abstract: Developers of novel or improved front-end circuits for biopotential recordings 
using dry electrodes face the challenge of validating their design. Dry electrodes allow 
more user-friendly and pervasive patient-monitoring, but proof is required that new devices 
can perform biopotential recording with a quality at least comparable to existing medical 
devices. Aside from electrical safety requirement recommended by standards and concise 
circuit requirement, there is not yet a complete validation procedure able to demonstrate 
improved or even equivalent performance of the new devices. This short review discusses 
the validation procedures presented in recent, landmark literature and offers interesting issues 
and hints for a more complete assessment of novel biopotential front-end. 
Keywords: biomedical front-end; dry electrodes; biopotentials recording 
 
1. Introduction 
Biopotential signals such as electrocardiogram (ECG), electroencephalogram (EEG), electromyogram 
(EMG) electroculogram (EOG), etc. are extensively used in clinical practice to assess the physical 
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condition and health status of patients [1]. Although the diagnosis of diseases or abnormalities is still 
carried out in hospitals by expert practitioners, there is a modern trend of non-invasive, unobtrusive 
and long-lasting patient’s monitoring outside the clinical environment. This trend has surfaced over the 
last few years and led to the development of a number of non-invasive monitoring devices (i.e., [2,3]), 
which can also be personal or home-based. 
This is particularly true for ECG and EEG (i.e., heart and cardiovascular disease monitoring and 
Brain Computer Interface). Thus, in order to comply with home monitoring requirements, many of 
those novel devices claim the capability of recording electrophysiological signals continuously, with 
none (or very little) signal degradation over time and without the need for expert supervision [3,4]. 
Although some of those new technologies have been previously reviewed (i.e., [5]), existing reviews 
focus on claims and technologies to achieve long-term monitoring and/or dry electrode. This review 
focuses on the methodology that authors have successfully employed over the past few years to 
achieve and demonstrate equivalent of even better recordings, as opposed to other existing and proven 
hardware devices. 
Quite a few of those technologies have become commercially successful [6–8]. However, given the 
small number of subjects employed for each study, and the intrinsic resistance -towards the adoption of 
new techniques, the majority of the devices suitable for long-term monitoring are still relegated to 
restricted research fields and/or as experimental devices, despite the efforts of researchers and authors 
in validation experiments.  
Most successful biomedical front-end validation approaches are reviewed, the similarities  
between techniques are highlighted, and possible guidelines for future biomedical front-end validation  
are suggested. 
From the existing literature, it is possible to infer some common strategies for validating the 
performance of biomedical analogue front-ends: namely, (a) the quantitative measurement of electrical 
circuit characteristics (i.e., circuit gain, frequency response, etc.); (b) qualitative evaluation of common 
physiological signal (i.e., recording from a very small population of healthy subjects); and (c) comparative 
assessment with a reference device (i.e., performed by comparing biopotential recordings acquired at 
the same time or at different times by the novel device and an existing medical device employed in 
clinical environment).  
In this review, we present and criticize the common traits of the qualitative measurement of electrical 
circuit characteristics, discussing the choices of designers in performing some specific bench tests; we 
also stress the importance of a quantitative and more standardized biopotential signal evaluation. 
2. Device Evaluation and Comparison Methods 
2.1. Quantitative Measurement of Electrical Circuit Characteristics (a) 
A front-end circuit suitable for biopotential recording must meet only concise specifications 
regarding the frequency band suitable for a specific diagnostic application (e.g., 0.05–150 Hz band for 
diagnostic grade ECG). [2,4]. However, there are no stringent specifications about the whole frequency 
response, for example in the vicinity of the band limits (this can change the diagnostic information 
provided). Some studies provide the frequency response of the circuit as a bode plot (magnitude) [9–17].  
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Unfortunately, off-the-shelf patient signal generators which are used for the periodic test of medical 
equipment and also for biopotential amplifier evaluation do not provide a continuous set of frequencies 
to perform a full frequency sweep. Normally they provide only sine waves at few (e.g., 5–10), 
predetermined frequencies in the range of 0.01 to 150 [Hz], which is too few to properly cover the full 
extent of the bio-signal bandwidth [4]. Additionally, the so-called patient simulators are designed to 
provide a differential signal which suits the majority (but not the totality) of biopotential front-ends. 
Further, it should be noted that the patient signal generators are designed to test the response of the 
circuit without the electrodes, which for some devices are incorporated into the design [13,18,19]. 
However, as evident in some designs, neither electrodes nor physical contact are necessary to achieve a 
biopotential recording [7,15,20,21].  
Methods that test the frequency response of biomedical front-end that are different from a frequency 
sweep and based on the delay imposed to a well characterized pulsed wave (triangular and/or square) 
have been developed over the years, particularly for ECG recorders [22,23]. The evaluation methods 
based upon square and triangular pulse results are particularly useful to characterize overall 
performance of electrocardiographic equipment. The device under test needs to maintain negligible 
phase distortion to avoid the deformation of cardiac waveforms, while coping with the presence of 
abrupt voltage gradients (i.e., pacemaker pulses) [24,25]. However, comparison with fully artificially 
generated ECG signals (a normal feature of patient simulators) seems to supersede such a test and 
relegate it to the final stage of validation, prior to commercialization. Of note, since that there are 
commercially available low amplitude signal generators which should be able to generate the required 
sine wave sweep as well as the mentioned pulsed waveforms; a complete characterization of the 
frequency response of a front-end circuit for biopotential recording is important and desirable. 
Aside from the gain and frequency response characteristics, a novel biopotential front-end usually 
includes information about power consumption [4,10,16,17,19,26–29]. In line with the growing 
demands of mobile monitoring [10,19], it is now a requirement that the power consumption of a 
monitoring device is at least in the order of a few µW. However, this requirement becomes not so 
compelling when the power consumption of interconnected circuits such as memorization or 
transmission devices [3,14,30] results higher (sometimes by orders of magnitude) than that of the 
biopotential front-end. Of note are several designers who reduced the power consumption of both the 
analogue and digital sections (sometimes including ADC) in order to break the barrier of the 1mW per 
biopotential front-end or channel [10]. 
Another important result that designers report in their specification table is the noise figure or  
noise-frequency relationship detailed plots. As it is known that some biomedical signals have 
important frequency content at very low frequencies (<0.5 Hz) [1,2,4], it is important that the proposed 
front-end exhibits particular high performance in terms of noise at very low frequencies. Additionally, 
since those biomedical front-ends will be interfaced to the employing electrode's source/the subject’s 
skin, it is important to consider the noise performance of the proposed front-end compared with the 
electrodes that will be recommended for use in combination with it [30,31]. As a general rule of 
thumb, it is possible to say that a biomedical front-end should exhibit a noise magnitude of 1.0 µVRMS 
or lower at very low frequencies (i.e., 1 Hz) in order to outperform at least the standard biomedical 
electrodes [32]. Despite the importance of information on noise performance, it is not always present 
in the specification summary of the proposed devices. Most importantly, the noise performance rarely 
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includes the electrodes or the digital interface/transmitter, which is important information to give to the 
end user, particularly for custom made dry electrodes [15]. 
Input impedance value and its relationship to frequency is another desirable specification to have in 
the summary table of a biomedical front-end design. Most modern designs claim ultra-high input 
impedance [4,6–8,11,14,15,20] and dry electrode suitability. However, designers claiming ultra-high 
input impedance can only give an estimate of the input impedance (except [20]) and clarify that 
Printed Circuit Board (PCB) designs must be carefully engineered and manufactured to preserve the 
estimated value for input impedance [7,11,15]. A successful design solution, implemented in the 
Plessey sensors [6] to preserve the input impedance, provides the end user with a properly 
manufactured little PCB encapsulated into an epoxy shielded container. This solution ensures that the 
ultra-high input impedance value is within the estimated specifications. Alternatively, some innovative 
designs have been presented as ‘on-chip’ designs [20]. Designers deciding to integrate the full 
biomedical front-end on chip, while ensuring preservation of circuit characteristics, leave the PCB 
designer (the end user) with the burden of designing a circuit board which preserves the input 
impedance value and possibly requires further stages of amplification/filtering [6,20]. 
While the majority of the reviewed biomedical front-ends focus on the evaluation and 
demonstration of better recording capabilities of a single channel front-end; biopotentials often require 
simultaneous acquisition of multiple channels (i.e., multi-channels EEG and 12-lead ECG [33]). 
Unfortunately, aside from a few notable examples [15,34], multi-channel design recommendations 
(i.e., how to use the proposed design in real scenarios such as a full 10–20 EEG montage) are rarely 
addressed as designers focus on the evaluation of a single channel, implying that multi-channel 
application is a trivial extension of the design. Unfortunately, as a biomedical front-end needs to cope 
with large common mode noises (i.e., power line and harmonics noise) [1,35,36], issues on how to share 
a common reference (a common issue in EEG recording) and strategies on how to provide a proper 
grounding connection to the subject are rarely addressed and characterized by designers [15,16,37], even 
though they are known to be the cause of degradation of the Common Mode Rejection Ratio (CMRR). 
Often (see [29,38]) the CMRR is estimated and the circuit used for its estimation is presented. 
However, as mentioned above, this is a simple instrumentation exercise; for the majority of designs it 
only accounts for CMRR degradations because of the tolerance of the employed components. Of note, 
CMRR requirements are specified in the standard normative and biopotential amplifiers are needed to 
comply with the specified values and tests [22,23,39]. However, these tests are once again relegated to 
the final evaluation prior to commercialization. 
2.2. Qualitative Physiological Signal Evaluation Characteristics (b) 
Physiological signal recording capabilities of the proposed design are often qualitatively evaluated, 
presenting sample recordings usually from one, but occasionally a handful of healthy subjects. 
Although the evaluation of physiological signal recording capability performed using at least one 
subject may have a significant visual impact, it does not substitute a clinical evaluation of the proposed 
design. In paper reporting particularly there is a limited number of recording traces (sometimes only 
one); therefore, it is not clear how many subjects have actually been used and how the particular traces 
were selected among the various recordings.  
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In the case of ECG front-ends, there are not many features (aside from the raw presentation of 
traces) that benefit from the new design. In contrast, for EEG front-end designs, the most common 
elicited brain signal feature appears to be the alpha wave replacement phenomenon known to occur 
when a relaxed awake adult subject closes their eyes for few seconds [1]. As this test is very easy to 
perform, almost all the biopotential front-end reviewed claimed that EEG recording capabilities 
presented a ‘difference between eyes open and closed’ in the frequency domain. 
While it is true that the alpha wave phenomenon is much more evident in the frequency domain [1,39], 
standard 5 or 10 second traces presenting the raw data together with a diagram or specific position 
from the 10–20 system could prove helpful in the visual evaluation of recordable data quality, particularly 
if physicians are targeted users [39]. Thus, designers should always include the time domain as well as 
the frequency domain plot of the alpha wave replacement phenomenon used for the evaluation. 
Data excerpts representing raw data recorded from one or more subjects recorded several hours apart 
are particularly elucidative of the long-term monitoring capabilities of the proposed hardware, especially 
if they are accompanied by Signal to Noise Ratio (SNR) or other qualitative measurements [14,40]. 
Additionally, where new kinds of signals or novel recording techniques are presented, standard parallel 
recording of physiological data (although this may complicate the setup of devices) should always be 
presented [41,42]. 
2.3. Comparative Assessment with a Reference Device (c) 
Qualitative biopotential signal evaluation is achieved performing parallel (acquired simultaneously) 
or serial (at different time) recordings against a commercial device (used in daily clinical practice or 
recognized (i.e., FDA approved) as suitable for it) considered as a reference [13,15,16,19,20,43–45]. It 
is normally performed in a hospital or clinical environment under the supervision of expert staff 
(ethical clearance and patients’ consent are usually required), and sometimes this evaluation precedes 
the proper clinical trial. As these kinds of recordings normally involve the use of multiple devices, the 
electrode placement can result problematic and cumbersome. 
Other designers [20,46] assumed as a reference standard of their own front-end or pre-acquired 
data, recorded using standard gelled electrodes on prepared skin and assuming the noise figure of their 
amplifier to be lower than the standards gelled electrodes. Unfortunately, this raises doubt as to what 
exactly is accepted as a reference standard by designers. 
For most of the reviewed devices, a parallel data acquisition was performed. Designers approaching 
this task face a number of challenges such as device synchronization, cross-talking and gain 
normalization; obviously, the correspondent electrodes of the two devices cannot be placed at exactly 
the same point. Furthermore, once the data is collected, designers must find a meaningful way to 
compare the recorded signal [14,15,30,47]. 
Device synchronization does not present much of a problem and can be solved by acquiring a 
common artificially generated signal (i.e., a coded sequence of pulses); it can also be achieved by 
artefact synchronization. For example, during parallel EEG recordings, practitioners can ask the 
subject to perform some distinctive actions such as eye blinking or jaw clenching, which can later be 
used to perform recording synchronization [15].  
Machines 2014, 2 92 
 
 
Crosstalk between devices can be an issue, particularly when two distinct ECG devices need to 
share common grounding connections (normally a driven ground configuration and often referred to as 
Driven Right Leg or DRL [1,37]). Without delving into the advantages and disadvantages of this well 
known technique, it is possible to understand that two different amplifiers connected to different pairs 
of electrodes (even if very close) may measure a different common mode signal, hence generating a 
crosstalk through the shared ground connections. 
This issue can be solved efficiently by employing ECG front-end designs that do not use a DRL;  
or by avoiding the connection of the DRL, assuming that under controlled and shielded environments, 
the CMRR of the front-ends is high enough to measure an accurate ECG. Alternatively, assuming that 
the input impedance of the front-end is high enough, the same pair of electrodes can be employed 
(front-ends in parallel connection) [41]. Alternatively, signals recorded from the two devices need to 
be carefully evaluated. An example of careful signal evaluation in the case of parallel recordings 
performed on volunteer subjects and on a fully sedated animal model during a cardiac catheterization 
is described in [42,43]. In both studies, the machines were connected serially (one after the other) and 
disconnected in reverse order; the frequency content of biopotential signals recorded by each device 
was analyzed, comparing when the machines were alone to when they were connected, and ensuring 
none or negligible effect over reciprocal signal recording capabilities. Additionally, signals were 
scored and evaluated by trained medical staff present during the procedures. 
For EEG recordings, from the existing literature [15,30,47], it is possible to gather that given the 
known high correlation of brain signals during elicited tasks [15,30,47], a practical way to test EEG 
front-ends in parallel is to surround each electrode connected to the device under test with a number of 
electrodes connected to the reference device. Then evaluate the correlation between the signal recorded 
by the device under test and each of the signals recorded by the reference device, as well as their 
average which in both cases should score very high (i.e., >0.9) [15,30].  
As an additional test, EEG devices can be compared serially. This can be done using elicited 
features such as Somato-Sensory Evoked Potential (SSEP) which compares the timing and amplitude 
of recorded potentials from exactly the same 10–20 standard locations [15]. 
3. Recommendations and Comments 
As already mentioned, frequency response of biopotential front-ends must be evaluated and tailored 
to the specific target signal. Hence, before starting the physiological signal evaluation, a full 
instrumental characterization of both (the reference and the ‘under-test’) devices is mandatory. 
Additionally, where possible, the frequency bandwidth of the device under test should be adjusted to 
replicate the reference device. This is not a simple task. In particular, the frequency response at the 
limits of the bandwidth may be significantly different because of use of dissimilar filters (by type 
and/or order), and also for the presence of not-excludable, hardware, notch filters (at power line 
frequency). In this case, a more accurate comparison between the recorded signals can be conducted 
after a software pre-processing (i.e., by applying high-order, zero phase lag filters) that limits the 
bandwidth to a subset of the original band (e.g. excluding the edges), in which the frequency response 
is surely more comparable. Similarly, frequency normalization should be applied as well for ECG 
front-end evaluation [15,19,41,42].  
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In the case of qualitative physiological signal evaluation performed using pre-recorded data (i.e., [46]), 
time correlation between signals could once again be used as a means of comparison. However, in this 
case designers should clarify how the test is coping with the natural physiological variability (i.e., heart 
rate variability in the case of the ECG) and this could raise other questions. 
One can also note that qualitative physiological signal evaluation performed using only standard 
gelled electrodes, and the same analogue front-end under test (i.e., [20]) could be assimilated to merely 
compare the performances of electrodes [31]; hence, they may be less representative of the better 
recording capabilities, unless the electrodes are part of the design and properly characterized together 
with the analogue front-end [11,15,46,48]. 
In summary, from the reviewed literature it is possible to suggest some general guidelines which, 
aside from that of the standards, can be used when performing the evaluation of novel biopotential 
front-ends. Namely, almost all of the reviewed front-end circuits have been fully characterized 
(evaluation a). Not all of the authors presented the full extent of quantitative physiological signal 
evaluation. However, they have all been able to give a statement on the improvements in recording 
capabilities for their designs. This is summarized in the following Table 1 where the specifications and 
evaluation results presented in the reviewed studies are reported in a synoptic way. 
As it is possible to infer from the table, although there is an apparent lack of uniformity in what 
designers think is compelling or necessary when they present the performance of their designs, almost 
all of them address the quantitative circuit evaluation to demonstrate their circuit as fit for biopotential 
recordings, such as circuit bandwidth, input impedance and noise figure. Aside from the synoptic 
Table 1, we also ordered the reviewed landmark literature onto a schematic roadmap (see Figure 1). As 
it is possible to infer from the roadmap, the very first bold step towards a proper characterization of a 
biopotential amplifier which claimed enhanced capabilities (dry and contactless) was in 2002 [7]. 
Since then, starting in 2008 (after a six year gap), every year at least one landmark paper has presented 
a novel amplifier with improved recording capabilities (see Table 1). The trend was not broken in 
2013, where, although, the authors claim that the tests are far from being completed (hence we have 
not reviewed it in details), another improved dry electrodes amplifier for single ended recording was 
presented [42,43]. We also note that a larger time gap is present for the contactless feature. Remote 
(contactless), recording of bio potentials showing excerpt of data have been presented in 2002 [7] (1 m 
of distance detection of ECG) and then in 2010 [15] (EEG recorded with interposition of insulation 
layer). Unfortunately, there is not a standard in testing the quality of contactless electrodes and only  
in [15] authors make the effort to characterize the artifact as well as the clean biopotential recordings 
against a comparison device. Therefore, we reviewed those as only “dry” electrodes.  
We conclude that, aside from the table with electronic characterization of the proposed novel front-end, 
a proper quantitative physiological signal evaluation also showing raw traces can add more information 
to claims such as the long-term monitoring of contactless recordings to facilitate their clinical 
acceptance. Of course, quantitative and qualitative evaluations of physiological signals do not 
represent a substitute to mandatory tests of compliance with the technical standards and proper  
multi-centre pre-clinical studies.  
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Table 1. Synoptic table of the assessment of biopotential front-ends performed by the 
reviewed literature. 
Reference— 
Type of Signal—
Type of Electrodes 
Recommended 
Custom Chip 
Design/Off—
Shelf 
Components 
Input 
Impedance 
—Noise 
Figure 
Power 
Consumption 
and Power 
Supply Range 
Multichannel  
Design 
Available 
Type of Evaluation (a, b, c). 
See Introduction 
[6]—ECG, EEG, 
EMG—integrated 
dry electrode 
Both 
20 GΩ//15 pF
—marked as 
'to be defined' 
Bipolar ±2.4 V 
to ±4 V 
2.5 mA supply 
current 
NA 
a: only gain and bandwidth 
are declared 
[7]—ECG, EEG, 
EMG—contactless 
and dry electrodes 
Made with 
off-shelf 
component 
(also basic 
schematic of 
Plessey [6]) 
15 GΩ 
estimated at 
1 Hz—
70 nV/Hz 
estimated at 
1 Hz 
NA NA 
a: bandwidth and noise 
b: ECG recordings in parallel 
with photo-plethysmographic 
device 
[15]—EEG—
contactless and dry 
electrodes 
Made with 
off-shelf 
component 
(custom PCB 
design) 
>15 TΩ//2 pF 
—noise 
estimation at 
10 Hz (include 
electrodes and 
digital 
transmitter 
Unipolar/bipolar 
up to ±18 V 
(limited to 3.3 V 
due to wireless 
transmitter) 
Current 
consumption: 
<1 mA per 
channel 
Yes (fully 
described in 
prior art: [19] 
a, b, c: full electronic 
characterization (no CMRR), 
qualitative evaluation of 
signal performed by 
neurophysiologist, 8 + 3 
subjects for parallel 
evaluation against two 
different sample devices 
[29]—ECG, EEG, 
EMG—standard 
electrodes 
Made with 
off-shelf 
component 
NA 
2.7 to 5.5 V 
Current 
consumption: 
150 µA 
NA 
Only a (include CMRR 
characterization) and partial 
b, one single ECG shown 
[20]—ECG, EEG, 
EMG—dry 
electrodes 
Custom chip 
and custom 
PCB design 
50 TΩ//60 fF 
200 nV/Hz 
estimated at 
1 Hz 
3.3 V 
Current 
consumption: 
1.5+3.3 µA 
Not shown 
a (include CMRR); b (no 
EEG traces in time domain 
shown) 
[45]—EEG—dry 
electrodes 
NA 
NA (although 
the device is 
commercially 
available 
authors should 
have provided 
a summary of 
specifications) 
NA Yes 
b, c: Authors calculate 
correlation between wet and 
dry electrodes similarly as 
shown in [15] 
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Figure 1. Synoptic roadmap of the landmark reviewed literature. 
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